Early detection of COPD in primary care: Screening by invitation of smokers aged 40 to 55 years

British Journal of General Practice

Volumn 54, Issue 500, 2004, Pages 201-206

  Stratelis, Georgios ^a,c   Jakobsson, Per ^a   Molstad, Siguard ^b   Zetterstrom, Olle ^a  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^b Unit of Research and Development in Primary Care   (Sweden)

^c Vardcentralen Brinken ^*  (Sweden)

Author keywords

Brochitis; Chronic; Chronic obstructive; Logistic regression; Pulmonary disease; Screening; Smoking; Spirometry

Indexed keywords

ADULT; ADVERTIZING; AGE; ARTICLE; AWARENESS; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DISEASE CLASSIFICATION; DISEASE SEVERITY; DYSPNEA; EARLY DIAGNOSIS; EUROPE; FEMALE; GENDER; HEALTH CENTER; HUMAN; INCIDENCE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; PATIENT SELECTION; PHARMACY; POPULATION RESEARCH; PREVALENCE; PRIMARY MEDICAL CARE; PROSPECTIVE STUDY; QUESTIONNAIRE; RISK ASSESSMENT; RURAL AREA; SCREENING TEST; SPIROMETRY; STATISTICAL ANALYSIS; SWEDEN; SYMPTOMATOLOGY;

ADULT; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PRIMARY HEALTH CARE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING; SPIROMETRY; SWEDEN;

EID: 1442351167     PISSN: 09601643     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Global initiative for chronic obstructive lung disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Workshop report 2003. http://www.goldcopd.com (accessed 28 Jan 2004).
2. Murray CJL, Lopez AD. Alternative visions of the future: projecting mortality and disability, 1990-2020. In: Murray CJL, Lopez AD (eds). The global burden of disease: a comprehensive assessment of mortality and disability from diseases. Injuries and risk factors in 1990 and projected to 2020. (Global burden of disease and injury Vol 1). Cambridge, Massachusetts, USA: Harvard University Press, 1996: 361-395.
3. Britton M. The burden of COPD in the UK: results from the confronting COPD survey. Respir Med 2003; 97(suppl C): S71-S79.
4. van Schayck CP, Chavannes NH. Detection of asthma and chronic obstructive pulmonary disease in primary care. Eur Respir J 2003; 21 (suppl 39): 16-22.
5. Siafakas NM, Vermeire P, Pride NB, et al. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). Eur Respir J 1995; 8: 1398-1420.
6. Fletcher C, Peto R, The natural history of chronic airflow obstruction. BMJ 1977; 1: 1645-1648.
7. Lundback B, Lindberg A, Lindstrom M, et al. Not 15 but 50% of smokers develop COPD? - report from the Obstructive Lung Disease in Northern Sweden studies. Respir Med 2003; 97: 115-122.
8. 1. The lung health study. JAMA 1994; 272: 1497-1505.
9. Peña VS, Miravitles M, Gabriel R, et al. Geographic variations in prevalence and underdiagnosis of COPD. Chest 2000; 118: 981-989.
10. Standardization of spirometry: 1994 update. American Thoracic Society. Am J Respir Crit Care Med 1995; 152(3): 1107-1136.
11. Laitinen LA, Koskela K. Chronic bronchitis and chronic obstructive pulmonary disease: Finnish national guidelines for prevention and treatment 1998-2007. Respir Med 1999; 93(5): 297-332.
12. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society. Am J Respir Crit Care Med 1995; 152(suppl 5 pt 2): S77-S120.
13. Statistics Sweden 2001. Smoking prevalence in Sweden 2001. http://www.scb.se (accessed 28 Jan 2004).
14. Boyle P. Screening. Eur Respir J 2003; 21 (suppl 39): S3-S15.
15. Zielinski J, Bednarek M, Know the age of your lung study group. Early detection of COPD in a high-risk population using spirometric screening. Chest 2001; 119: 731-736.
16. Kanner RE. Preclinical COPD: description, recognition, and therapy. In: Cherniack N (ed). Chronic obstructive pulmonary disease. Philadelphia: WB Saunders, 1991: 420-425.
17. Ekberg-Jansson A, Andersson B, Bake B, et al. Neutrophil-associated activation markers in healthy smokers relates to a fall in DL(CO) and to emphysematous changes on high resolution CT. Respir Med 2001; 95: 363-373.
18. Walters N, Coleman T. Comparison of the smoking behaviour and attitudes of smokers who attribute respiratory symptoms to smoking with those who do not. Br J Gen Pract 2002; 52: 132-134.